학술논문

Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19
Document Type
Article
Source
In: Journal of Antimicrobial Chemotherapy. (Journal of Antimicrobial Chemotherapy, 1 October 2022, 77(10):2688-2692)
Subject
Language
English
ISSN
14602091
03057453